Novartis Biociencias S.A. (Brazil)

Novartis Biociencias S.A. is a company located in Sao Paulo, Brazil. It was created in 1996 through the merger of Ciba-Geigy and Sandoz. The company has a rich history in the development of innovative products, with its predecessor companies specializing in the production of chemicals and pharmaceuticals. Novartis focuses on innovation to meet the unmet needs of patients worldwide. Their main products include a global portfolio of over 50 patented innovative medicines, many of which are leading products in their therapeutic areas and fall under the category of immunobiological drugs. These drugs are considered one of the greatest advancements in history and have significantly improved global health. Novartis also offers biosimilar and generic medicines, with their division Sandoz being a global leader in the industry. Sandoz provides over 1,000 different types of high-quality and affordable medicines in various therapeutic areas. Novartis also collaborates with strategic commercial partners to address complex challenges in healthcare ecosystems. They are committed to informing and updating patients about any discontinuation of their products as per regulatory requirements. For more information and clarification about their products, customers can contact their Customer Information Service.